000 01434 a2200385 4500
005 20250518052456.0
264 0 _c20200305
008 202003s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2019.105743
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSomensi, Nauana
245 0 0 _aCarvacrol suppresses LPS-induced pro-inflammatory activation in RAW 264.7 macrophages through ERK1/2 and NF-kB pathway.
_h[electronic resource]
260 _bInternational immunopharmacology
_cOct 2019
300 _a105743 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aCymenes
_xpharmacology
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xmetabolism
650 0 4 _aLipopolysaccharides
650 0 4 _aMice
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aNitrites
_xmetabolism
650 0 4 _aPhagocytosis
_xdrug effects
650 0 4 _aRAW 264.7 Cells
700 1 _aRabelo, Thallita Kelly
700 1 _aGuimarães, Adriana Gibara
700 1 _aQuintans-Junior, Lucindo José
700 1 _ade Souza Araújo, Adriano Antunes
700 1 _aMoreira, José Cláudio Fonseca
700 1 _aGelain, Daniel Pens
773 0 _tInternational immunopharmacology
_gvol. 75
_gp. 105743
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2019.105743
_zAvailable from publisher's website
999 _c29951293
_d29951293